Ubiquitin-conjugating enzyme E2D 4 (Ube2d4) plays a central role in the highly regulated process of protein ubiquitination, a fundamental mechanism governing the fate of proteins within cells. As a member of the ubiquitin-conjugating enzyme family, Ube2d4 is predicted to possess ubiquitin conjugating enzyme activity, functioning upstream of or within the intricate machinery of protein ubiquitination. This enzymatic activity is crucial for mediating the covalent attachment of ubiquitin molecules to target proteins, marking them for various cellular fates such as degradation, signaling, and DNA repair. The diversity of cellular processes regulated by Ube2d4 highlights its significance in maintaining cellular homeostasis and responding to dynamic environmental changes. Inhibition of Ube2d4 is achieved through a spectrum of mechanisms, each targeting specific aspects of its function. Direct inhibitors act by disrupting the ubiquitin charging process, preventing the formation of thioester bonds between Ube2d4 and ubiquitin. This interference impedes the ubiquitin conjugation cascade, leading to the accumulation of unmodified substrate proteins. Indirect inhibitors, on the other hand, modulate cellular pathways associated with Ube2d4 activity. For instance, inhibition of neddylation disrupts Ube2d4's activation, reducing its ubiquitin conjugation activity.
Indirect inhibitors can also influence Ube2d4 by inducing oxidative stress, altering the redox environment crucial for optimal ubiquitin conjugation. Additionally, inhibiting deubiquitinating enzymes promotes the accumulation of ubiquitinated proteins, indirectly suppressing Ube2d4 by facilitating ubiquitin conjugation on its substrates. The intricate network of direct and indirect inhibitors unveils the multifaceted regulatory mechanisms governing Ube2d4, emphasizing its central role in orchestrating the fate of cellular proteins. Understanding the intricacies of Ube2d4 and its inhibition provides valuable insights into the broader landscape of cellular regulation. The ubiquitin-proteasome system, in which Ube2d4 is a key player, serves as a critical hub for maintaining cellular proteostasis, responding to stress, and regulating various cellular processes. The inhibition of Ube2d4 presents a nuanced approach, illustrating the complexity of targeting a specific component within this intricate system. By dissecting the mechanisms of inhibition, researchers can unravel the interconnected pathways and cellular events that govern Ube2d4's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibits Ube2d4 directly by blocking ubiquitin conjugating enzyme activity. PYR-41 covalently modifies the active site of Ube2d4, preventing the formation of ubiquitin conjugates and impeding its enzymatic function in the ubiquitination process. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits Ube2d4 indirectly by targeting the NEDD8-activating enzyme (NAE) and inhibiting neddylation. MLN4924 disrupts the activation of NEDD8, preventing the neddylation of Ube2d4. Unneddylated Ube2d4 is less active in ubiquitin conjugation, leading to indirect inhibition of its enzymatic function. | ||||||
(+)-Nutlin-3 | 675576-97-3 | sc-222085 sc-222085A | 500 µg 1 mg | $94.00 $122.00 | ||
Inhibits Ube2d4 indirectly by disrupting the p53-MDM2 interaction. Nutlin-3 binds to MDM2, preventing its interaction with p53. Stabilized p53 inhibits Ube2d4 transcription, reducing the cellular levels of Ube2d4 and indirectly suppressing ubiquitin conjugation activity. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
Inhibits Ube2d4 indirectly by targeting the NEDD8-activating enzyme (NAE) and inhibiting neddylation. MLN7243 disrupts the activation of NEDD8, preventing the neddylation of Ube2d4. Unneddylated Ube2d4 is less active in ubiquitin conjugation, leading to indirect inhibition of its enzymatic function. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Inhibits Ube2d4 indirectly by inducing oxidative stress. Auranofin generates reactive oxygen species (ROS), activating the Keap1/Nrf2 pathway. Nrf2 induces the expression of antioxidant proteins, indirectly suppressing Ube2d4 activity by reducing the cellular oxidative stress required for optimal ubiquitin conjugation. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
Inhibits Ube2d4 directly by disrupting the ubiquitin charging process. NSC697923 interferes with the formation of thioester bonds between Ube2d4 and ubiquitin, hindering the ubiquitin conjugation cascade. Direct inhibition of Ube2d4 by NSC697923 results in the accumulation of unmodified substrate proteins. | ||||||
WP1130 | 856243-80-6 | sc-364650 sc-364650A | 10 mg 50 mg | $490.00 $1484.00 | 1 | |
Inhibits Ube2d4 indirectly by inhibiting deubiquitinating enzymes (DUBs). WP1130 inhibits DUBs, preventing the removal of ubiquitin from Ube2d4-bound substrates. This leads to the accumulation of ubiquitinated proteins and indirectly suppresses Ube2d4 activity by promoting ubiquitin conjugation on its substrates. | ||||||